Antineoplastic agents are the type of drugs that inhibit the maturation and proliferation of neoplasms. These agents travel into the human body and destroys the cancerous cells. These drugs/agents are not only used for different cancers but are used in conjunction with surgery, radiotherapy and immunotherapy for many solid tumors particularly for metastatic.

The global market for anti-neoplastic agents is expected to reach around USD 150 billion by the end of the forecast period and is expected to grow at a striking CAGR of ~8.0% during the forecast period 2016-2022.

Key Players for Global Anti-Neoplastic Agents Market:

Some of the key players in this market are: Amgen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, Bayer AG, Aspen Holdings, Pfizer Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Teva pharmaceutical Industries Ltd, Genentech Inc., AbbVie Inc. and others.

Market Segments:

Global Anti-neoplastic agents market has been segmented on the basis of type which comprises alkylating and alkylating-like agents, antimetabolites, antitumor antibiotics, plant alkaloids, hormonal agents, and miscellaneous agents. On the basis of end users; market is segmented into hospitals, clinics, research institutes, cancer rehabilitation centers and others.

The market for antineoplastic is growing at a reasonably good rate. Growing new cases for neoplasms around the globe and increasing need for cost effective treatments to cure the neoplasms has fueled the growth of anti-neoplastic agents market.

Study Objectives Global Anti-Neoplastic Agents Market:

• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global Anti-neoplastic agents market
• To provide insights about factors affecting the market growth
• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by type, by end user and other sub segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Table of Content

1. Report Prologue
2. Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 PORTERS Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger And Acquisition Landscape

5.7 Upcoming Trends

5.7.1 Market Trends

5.7.2 Technological Trends

5.7.3 Insurance & Regulations

5.7.4 Others

6. Anti-Neoplastic Agents Market By Types
7. Anti-Neoplastic Agents Market By Treatment
8. Anti-Neoplastic Agents Market By Region

...continued

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.